Recombinetics Closes $34 Million in Series A Funding

Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to [...]

Recombinetics Closes $34 Million in Series A Funding2022-02-28T09:20:54-06:00

Jim Kilman Elected to Recombinetics Board of Directors; Dr. Robert Montgomery Selected as Lead Strategist for Regenerative Medicine Advisory Board

New York-based Expertise Added for Capital Raise and Financing Strategies and Regenerative Medicine Organ Development and Transplantation Program  ST. PAUL, Minn. Recombinetics (RCI), a pioneer in gene editing solutions for human health and animal agriculture, today announced two new appointments to its governance and strategic advisory boards. “The addition of [...]

Jim Kilman Elected to Recombinetics Board of Directors; Dr. Robert Montgomery Selected as Lead Strategist for Regenerative Medicine Advisory Board2018-01-17T21:41:43-06:00

Growing Human Organs in Pigs

Our company's work in exo-transplantation for regenerative medicine is featured on Facebook Watch's On the Fringe show. Click on the box below to watch it.    

Growing Human Organs in Pigs2020-08-14T16:42:38-05:00
Go to Top